Advertisement

Topics

Phillips Ormonde Fitzpatrick Company Profile

19:05 EDT 20th September 2018 | BioPortfolio

Phillips Ormonde Fitzpatrick has been at the forefront of intellectual property law in Australia since its establishment in Melbourne, in 1888. Having evolved to employ more than 140 people, we have expanded to include offices in Sydney and Adelaide, and have the ability to act directly in New Zealand. The Phillips Ormonde Fitzpatrick group of businesses offers a broad spectrum of premium IP services.
Phillips Ormonde Fitzpatrick Patent and Trade Mark Attorneys includes a large number of highly experienced professionals, qualified in a diversity of technologies, who specialise in obtaining and enforcing patents, trade marks and designs throughout the world - in association with an extensive network of over 500 international associates.
Our affiliated law firm, Phillips Ormonde Fitzpatrick Lawyers, provides a range of legal services relevant to the procurement and enforcement of intellectual property. The firm provides advice in relation to IP litigation, licensing and contracts. It has a strong reputation in relation to patent litigation, where every lead lawyer handling a case has a degree in science, is a registered patent attorney, and is a lawyer that has practised in the patent field for many years.
IP Organisers Pty Ltd, our other affiliated company, provides intellectual property research and searching services, including patent and trade mark searches and watches. In addition, the company provides clients with IP portfolio audits, IP management and reporting services, and general commercialisation advice. IP Organisers also maintains IP Menu, a global guide to intellectual property resources on the Internet

Location

Level 23, 367 Collins Street
Melbourne
Victoria
3000
Australia

Contact

Phone: 61 3 9614 1944
Fax: 61 3 9614 1867
Email: adam.trumble@pof.com.au


News Articles [52 Associated News Articles listed on BioPortfolio]

Mallinkrodt’s Gary Phillips Joins OrphoMed as President & CEO

Gary Phillips has been named president and CEO of San Francisco-based OrphoMed. Phillips comes to OrphoMed from Mallinckrodt Pharmaceuticals (NYSE: MNK) where he was executive vice president and chief...

Midatech Pharma's chief executive officer Dr Jim Phillips to step down at the end of May

Dr Phillips's successor as CEO will be COO Dr Craig Cook, who has more than 20 years of international experience in the pharmaceutical, biomedical and high technology sectors

Milberg Tadler Phillips Grossman LLP Announces Investigation of BioScrip, Inc.

NEW YORK, March 8, 2018/PRNewswire/ -- Milberg Tadler Phillips Grossman LLP, an investor protection firm, has commenced an investigati...

Phillips-Medisize invites visitors to discuss connected health during Medtec Europe

Phillips-Medisize will be part of Medtec Europe in Stuttgart, Germany on April 17-19. A key element of Medtec Europe 2018 will be Smart Health and Technology Innovations

Midatech Pharma 'consistently delivering on sales growth', says CEO Jim Phillips

Jim Phillips, chief executive of Midatech Pharma Plc (LON:MTPH; NASDAQ: MTP) talks Proactive through the firms full year results which chart a year of both operational and financial progress. The ...

Government of Victoria:The Hon Gordon Rich-Phillips, Technology Minister, .Developing the Australian BioTech sector

In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to The Hon Gordon Rich-Phillips, Technology Minister at Victoria Government, Austral...

Die Anlagetipps der Woche: Phillips-Van Heusen (PVH) bietet starke Marken mit anziehender Marge, Merck ...

Phillips-Van Heusen (PVH) bietet starke Marken mit anziehender Marge, Merck wird für Mutige jetzt wieder interessant und Hella steht vor einem Rekordjahr. Aktien, Anleihen und Fonds für Privatanleg....

Phillips-Medisize expands Wisconsin medical facility to add drug handling capabilities

Phillips-Medisize, a Molex company, has completed another significant expansion to its New Richmond, Wisconsin, USA, medical facility, adding drug handling capabilities.

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Intense pulsed light is effective in treating postburn hyperpigmentation and telangiectasia in Chinese patients.

Intense pulsed light (IPL) has been used to treat postinflammatory hyperpigmentation and telangiectasia in Fitzpatrick type I -II skin. However, its therapeutic effects after superficial second-degree...

Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype.

Acne vulgaris (acne) is prevalent in individuals with skin of color, often with more frequent sequelae than in patients with lighter skin color. It is important to determine if there are also differen...

Retraction Note: Purified umbilical cord derived mesenchymal stem cell treatment in a case of systemic lupus erythematosus.

The Editor-in-Chief is retracting this article because the authors have not obtained consent to publish from the patient whose details are described in this case report. The article has been removed t...

Photodynamic therapy for rosacea in Chinese patients.

Rosacea is a common chronic cutaneous disorder which is characterized by flushing, erythema, papulopustules and telangiectasia. The pathogenesis of the disease is still unknown. A multifaceted approac...

The Effect of an Anti-Inflammatory Botanical Cleanser/Night Mask Combination on Facial Redness Reduction.

Facial redness is a common difficult to control cosmetic problem representing various phases of rosacea. Using anti-inflammatory/antioxidant botanicals in moisturizer formulations is a possible approa...

Clinical Trials [23 Associated Clinical Trials listed on BioPortfolio]

The Influence of Skin Pigmentation on UVB Induced Vitamin D Increase

Skin pigmentation (melanin) absorbs ultra violet type B (UVB) radiation found in sunlight and is believed to be responsible for darker-skinned persons' generally low 25(OH)D status. This p...

Caregiver Study Dr. Phillips

This study will examine whether a performing arts class will improve the well-being of primary unpaid caregivers of people with dementia

Primary Upper Limb Deep Vein Thrombosis. Is First Rib Resection Necessary?

The purpose of the study is to compare outcome of patients with effort thrombosis who were treated operatively to those treated nonoperatively

Light, Exercise Intensity and Mood in Overweight

The purpose of this study is to determine if an exposure to light in the morning has a positive influence on self-chosen exercise intensity on a bicycle ergometer in overweight and obese p...

Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III

The goal of this study is to establish the safety of high fluence LED-RL at fluence of 480 J/cm2 and 640 J/cm2 in healthy non-Hispanic, Caucasian subjects. The hypothesis is that high flue...

Companies [25 Associated Companies listed on BioPortfolio]

Phillips Ormonde Fitzpatrick

Phillips Ormonde Fitzpatrick has been at the forefront of intellectual property law in Australia since its establishment in Melbourne, in 1888. Having evolved to employ more than 140 people, we have e...

Chevron Phillips ChemicalCompany LLC

On July 1, 2000, Chevron Corporation and Phillips Petroleum Company, now ConocoPhillips, combined its worldwide petrochemical businesses, excluding Chevron’s oronite additives business, to form Chev...

Fitzpatrick, Cella, Harper & Scinto LLP

Fitzpatrick, Cella, Harper & Scinto (www.fitzpatrickcella.com), founded in 1971, is a leading national intellectual property law firm of nearly 150 lawyers with offices in New Yor...

Chevron Phillips Chemical Company LP

Chevron Phillips Chemical Company LP is an indirect wholly-owned subsidiary of Chevron Phillips Chemical Company LLC, one of the world’s top producers of olefins and polyolef...

Phillips & Cohen LLP

Phillips & Cohen LLP is the nation's most successful law firm representing whistleblowers. Qui tam lawsuits brought by Phillips & Cohen have resulted in civil and criminal recoveries totaling $5.3 bil...

More Information about "Phillips Ormonde Fitzpatrick" on BioPortfolio

We have published hundreds of Phillips Ormonde Fitzpatrick news stories on BioPortfolio along with dozens of Phillips Ormonde Fitzpatrick Clinical Trials and PubMed Articles about Phillips Ormonde Fitzpatrick for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phillips Ormonde Fitzpatrick Companies in our database. You can also find out about relevant Phillips Ormonde Fitzpatrick Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record